Oregon
The Oregon Prescription Drug Affordability Board is hosting a series of community forums to help the board with direction on how to move forward with the rising costs of prescription drugs
Eugene, OR – According to the state officials, the Oregon Prescription Drug Affordability Board was created out of Senate Bill 844 in 2021 to find ways to make prescription drugs more affordable for Oregonians by making recommendations to the Oregon Legislature.
Later, Senate Bill 192 directed the board to develop a plan for establishing upper payment limits on prescription drugs sold in Oregon and seek the public’s input on the effect of the rising costs of drugs in Oregon.
An upper payment limit is a limit on what purchasers within the state will pay for specific drugs identified by the board.
The Oregon Prescription Drug Affordability Board staff members will facilitate the free meetings in April and May.
Everyone is invited to attend, learn more about prescription drug costs, and tell their story of how costly prescriptions have affected their health, budget, and lives.
Lou Savage, a past director of the Department of Consumer Business Services and former Oregon insurance commissioner, will be the moderator.
He will present an overview of prescription drug pricing, explain why costs are high, and talk about the board’s work to make prescription drugs and insulin more affordable for Oregonians.
-
Oregon4 days ago“This is another Trumpian attack on children,” Oregon Sen. Merkley accuses Trump administration of taking away attorneys for unaccompanied children to make deportations easier
-
Eugene4 days agoEugene-Springfield Fire responds to structure fire that damaged home, shed and power pole
-
Eugene4 days agoEugene-Springfield Fire responds to apartment fire that seriously injured one resident near downtown Eugene
-
Eugene4 days agoEugene Police Department thanks local community after National Night Out event
-
Eugene4 days agoEugene Police motorcycle officers train with agencies across Oregon for motorcade operations
